Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered. - 2Israel launches new wave of attacks against Hezbollah in Beirut
- 3The Electric Bicycle Americans Can Confide in 2024
- 4Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back?
- 5Daily Briefing: A bad flu season gets worse
- My Excursion to Monetary Autonomy: Awesome ways to save cash
- US FDA investigates Takeda's blood disorder drug after pediatric death
- Vote in favor of your #1 Kind of Cap
- Figure out How to Pick the Right Dental specialist for Your Dental Inserts
- The Most Enrapturing Authentic Milestones to Visit
- From Fledgling to Master: Self-awareness in a Side interest
- Five held on suspicion of planning attack on German Christmas market
- NASA's giant moon rocket, in photos
- Nestlé says 413,793 KitKat candy bars stolen en route from Italy to Poland
